JIMRO CO., LTD.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Subsidiary
- Established
- 1977-11-08
- Employees
- 101
- Market Cap
- -
- Website
- http://www.jimro.co.jp
Clinical Trials
5
Active:0
Completed:5
Trial Phases
3 Phases
Phase 2:2
Phase 3:1
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (40.0%)Phase 2
2 (40.0%)Phase 3
1 (20.0%)Clinical Trial of Cilostazol Eluting Stent System (CES-1) in De Novo Coronary Artery Lesions
Not Applicable
Completed
- Conditions
- Coronary Artery Disease
- First Posted Date
- 2017-06-16
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- JIMRO Co., Ltd.
- Target Recruit Count
- 30
- Registration Number
- NCT03189641
- Locations
- 🇯🇵
Tokai University Hospital, Isehara, Kanagawa, Japan
🇯🇵Kitasato University Hospital, Sagamihara, Kanagawa, Japan
🇯🇵Saiseikai Yokohamashi Tobu Hospital, Yokohama, Kanagawa, Japan
Thrombectomy Revascularization of Intracranial Vessel OcclusioN by Originating From Japan (TRON1-Japan)
Not Applicable
Completed
- Conditions
- Acute Ischemic Stroke
- First Posted Date
- 2016-11-16
- Last Posted Date
- 2019-07-18
- Lead Sponsor
- JIMRO Co., Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT02964702
- Locations
- 🇯🇵
Kurume University Hospital, Kurume, Fukuoka, Japan
🇯🇵Brain Attack Center Ota Memorial Hospital, Fukuyama, Hiroshima, Japan
🇯🇵Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan
Renal Denervation on Quality of 24-hr BP Control by Ultrasound In Resistant Hypertension
Phase 3
Completed
- Conditions
- HypertensionVascular Diseases
- First Posted Date
- 2016-09-28
- Last Posted Date
- 2021-11-19
- Lead Sponsor
- JIMRO Co., Ltd.
- Target Recruit Count
- 140
- Registration Number
- NCT02918305
News
No news found